Scrambler therapy, a neurocutaneous stimulation device, appears to have a promising effect in relieving postherpetic neuropathy, according to a study published in the American Journal of Hospice & Palliative Medicine.
Ten patients were given Scrambler therapy as 30-minute sessions daily for 10 days at two centers. Pain was recorded before and after treatment.
The average pain score diminished by 95 percent within one month, with continued relief over the next two to three months. Researchers did warn, however, that further study is warranted.
The treatment is currently being tested at the Rochester, Minn.-based Mayo Clinic, Johns Hopkins University in Baltimore and University of Wisconsin-Madison. It is also being offered at Spero Pain Relief Therapy of Illinois in Riverwoods.
More Articles on Pain Management:
Study: Prescription Painkiller Overdose Deaths in Women Spike 400% in 10 YearsDr. Walter Schuyler Joins Pain Specialists of Charleston
Sibley Medical Center to Open Pain Management Clinic, Adds Dr. J. Richard Waggoner